(PAH3) Porsche Automobil Holding SE - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000PAH0038
Sports Cars, Suvs, Sedans, Hybrids
PAH3 EPS (Earnings per Share)
PAH3 Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.8% |
| Value at Risk 5%th | 36.5% |
| Reward | |
|---|---|
| Sharpe Ratio | 0.44 |
| Alpha Jensen | -1.99 |
| Character | |
|---|---|
| Hurst Exponent | 0.361 |
| Beta | 1.066 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.74% |
| Mean DD | 21.30% |
Description: PAH3 Porsche Automobil Holding SE November 03, 2025
Porsche Automobil Holding SE (XETRA: PAH3) is the holding company for Volkswagen Group’s premium brands, including Volkswagen, Audi, SEAT, ŠKODA, Bentley, Lamborghini and Porsche. It reports under two segments-Core Investments (the operating automotive business) and Portfolio Investments (strategic stakes in mobility and industrial-technology firms). The firm, headquartered in Stuttgart, Germany, was renamed from Dr. Ing. h.c. F. Porsche AG in November 2007.
Key recent metrics show the Core Investments segment generated €85 billion in revenue in 2023, with an adjusted EBIT margin of 11.2 %, while EV sales accounted for roughly 23 % of total vehicle deliveries, reflecting accelerating electrification. The company’s exposure to the Chinese luxury market remains a material growth driver, but it is also vulnerable to EU CO₂-emission standards and tightening credit conditions that can suppress discretionary spending on high-end vehicles.
For a deeper, data-driven dive into Porsche PAH3’s valuation assumptions and scenario analysis, you might find ValueRay’s research platform a useful next step.
PAH3 Stock Overview
| Market Cap in USD | 12,391m |
| Sub-Industry | Automobile Manufacturers |
| IPO / Inception | |
| Return 12m vs S&P 500 | -7.37% |
| Analyst Rating | - |
PAH3 Dividends
| Dividend Yield | 5.12% |
| Yield on Cost 5y | 4.17% |
| Yield CAGR 5y | -16.71% |
| Payout Consistency | 90.3% |
| Payout Ratio | 20.6% |
PAH3 Growth Ratios
| CAGR | -9.71% |
| CAGR/Max DD Calmar Ratio | -0.23 |
| CAGR/Mean DD Pain Ratio | -0.46 |
| Current Volume | 910.4k |
| Average Volume | 585.6k |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-21.81b TTM) > 0 and > 6% of Revenue (6% = -1.30b TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -1.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.03% (prev 40.88%; Δ -43.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 753.0m > Net Income -21.81b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (306.2m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 100.2% (prev -115.1%; Δ 215.3pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover -40.18% (prev 9.76%; Δ -49.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -59.26 (EBITDA TTM -22.04b / Interest Expense TTM 372.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.63
| (A) 0.02 = (Total Current Assets 2.97b - Total Current Liabilities 2.31b) / Total Assets 42.35b |
| (B) 0.70 = Retained Earnings (Balance) 29.48b / Total Assets 42.35b |
| (C) -0.41 = EBIT TTM -22.04b / Avg Total Assets 53.87b |
| (D) 3.81 = Book Value of Equity 29.68b / Total Liabilities 7.78b |
| Total Rating: 3.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.57
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 4.81% = 2.40 |
| 3. FCF Margin -3.48% = -1.30 |
| 4. Debt/Equity 0.22 = 2.48 |
| 5. Debt/Ebitda 0.06 = 2.50 |
| 6. ROIC - WACC (= -57.68)% = -12.50 |
| 7. RoE -54.18% = -2.50 |
| 8. Rev. Trend -50.07% = -3.76 |
| 9. EPS Trend -54.89% = -2.74 |
What is the price of PAH3 shares?
As of November 13, 2025, the stock is trading at EUR 37.28 with a total of 910,378 shares traded.
Over the past week, the price has changed by +5.82%, over one month by +10.75%, over three months by +2.90% and over the past year by +7.34%.
Over the past week, the price has changed by +5.82%, over one month by +10.75%, over three months by +2.90% and over the past year by +7.34%.
Is Porsche Automobil Holding SE a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Porsche Automobil Holding SE (XETRA:PAH3) is currently (November 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 32.57 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PAH3 is around 33.30 EUR . This means that PAH3 is currently overvalued and has a potential downside of -10.68%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PAH3 is around 33.30 EUR . This means that PAH3 is currently overvalued and has a potential downside of -10.68%.
Is PAH3 a buy, sell or hold?
Porsche Automobil Holding SE has no consensus analysts rating.
What are the forecasts/targets for the PAH3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.8 | 9.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.4 | -2.4% |
PAH3 Fundamental Data Overview January 01, 1970
Market Cap USD = 12.39b (10.73b EUR * 1.1543 EUR.USD)
Market Cap EUR = 10.73b (10.73b EUR * 1.0 EUR.EUR)
P/E Forward = 2.4981
P/S = 1.1957
P/B = 0.3034
Beta = 1.066
Revenue TTM = -21.64b EUR
EBIT TTM = -22.04b EUR
EBITDA TTM = -22.04b EUR
Long Term Debt = 5.35b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.27b EUR (from shortTermDebt, last quarter)
Debt = 7.62b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.38b EUR (from netDebt column, last quarter)
Enterprise Value = 15.66b EUR (10.73b + Debt 7.62b - CCE 2.69b)
Interest Coverage Ratio = -59.26 (Ebit TTM -22.04b / Interest Expense TTM 372.0m)
FCF Yield = 4.81% (FCF TTM 753.0m / Enterprise Value 15.66b)
WARNING: Negative Revenue TTM = -21.64b
FCF Margin = -3.48% (FCF TTM 753.0m / Revenue TTM -21.64b)
WARNING: Negative Revenue TTM = -21.64b
Net Margin = 100.8% (Net Income TTM -21.81b / Revenue TTM -21.64b)
WARNING: Negative Revenue TTM = -21.64b
Gross Margin = 100.2% ((Revenue TTM -21.64b - Cost of Revenue TTM 33.0m) / Revenue TTM)
Gross Margin QoQ = 99.34% (prev none%)
Tobins Q-Ratio = 0.37 (Enterprise Value 15.66b / Total Assets 42.35b)
Interest Expense / Debt = 1.06% (Interest Expense 81.0m / Debt 7.62b)
Taxrate = 1.66% (24.0m / 1.44b)
NOPAT = -21.68b (EBIT -22.04b * (1 - 1.66%)) [loss with tax shield]
Current Ratio = 1.28 (Total Current Assets 2.97b / Total Current Liabilities 2.31b)
Debt / Equity = 0.22 (Debt 7.62b / totalStockholderEquity, last quarter 34.57b)
Debt / EBITDA = 0.06 (negative EBITDA) (Net Debt -1.38b / EBITDA -22.04b)
Debt / FCF = -1.83 (Net Debt -1.38b / FCF TTM 753.0m)
Total Stockholder Equity = 40.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -51.50% (Net Income -21.81b / Total Assets 42.35b)
RoE = -54.18% (Net Income TTM -21.81b / Total Stockholder Equity 40.26b)
RoCE = -48.33% (EBIT -22.04b / Capital Employed (Equity 40.26b + L.T.Debt 5.35b))
RoIC = -51.43% (negative operating profit) (NOPAT -21.68b / Invested Capital 42.15b)
WACC = 6.25% (E(10.73b)/V(18.35b) * Re(9.94%) + D(7.62b)/V(18.35b) * Rd(1.06%) * (1-Tc(0.02)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 64.52% ; FCFE base≈1.27b ; Y1≈906.0m ; Y5≈489.6m
Fair Price DCF = 45.79 (DCF Value 7.01b / Shares Outstanding 153.1m; 5y FCF grow -33.68% → 3.0% )
EPS Correlation: -54.89 | EPS CAGR: -2.45% | SUE: 0.00 | # QB: 0
Revenue Correlation: -50.07 | Revenue CAGR: 40.15% | SUE: 0.19 | # QB: 0
Market Cap EUR = 10.73b (10.73b EUR * 1.0 EUR.EUR)
P/E Forward = 2.4981
P/S = 1.1957
P/B = 0.3034
Beta = 1.066
Revenue TTM = -21.64b EUR
EBIT TTM = -22.04b EUR
EBITDA TTM = -22.04b EUR
Long Term Debt = 5.35b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.27b EUR (from shortTermDebt, last quarter)
Debt = 7.62b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.38b EUR (from netDebt column, last quarter)
Enterprise Value = 15.66b EUR (10.73b + Debt 7.62b - CCE 2.69b)
Interest Coverage Ratio = -59.26 (Ebit TTM -22.04b / Interest Expense TTM 372.0m)
FCF Yield = 4.81% (FCF TTM 753.0m / Enterprise Value 15.66b)
WARNING: Negative Revenue TTM = -21.64b
FCF Margin = -3.48% (FCF TTM 753.0m / Revenue TTM -21.64b)
WARNING: Negative Revenue TTM = -21.64b
Net Margin = 100.8% (Net Income TTM -21.81b / Revenue TTM -21.64b)
WARNING: Negative Revenue TTM = -21.64b
Gross Margin = 100.2% ((Revenue TTM -21.64b - Cost of Revenue TTM 33.0m) / Revenue TTM)
Gross Margin QoQ = 99.34% (prev none%)
Tobins Q-Ratio = 0.37 (Enterprise Value 15.66b / Total Assets 42.35b)
Interest Expense / Debt = 1.06% (Interest Expense 81.0m / Debt 7.62b)
Taxrate = 1.66% (24.0m / 1.44b)
NOPAT = -21.68b (EBIT -22.04b * (1 - 1.66%)) [loss with tax shield]
Current Ratio = 1.28 (Total Current Assets 2.97b / Total Current Liabilities 2.31b)
Debt / Equity = 0.22 (Debt 7.62b / totalStockholderEquity, last quarter 34.57b)
Debt / EBITDA = 0.06 (negative EBITDA) (Net Debt -1.38b / EBITDA -22.04b)
Debt / FCF = -1.83 (Net Debt -1.38b / FCF TTM 753.0m)
Total Stockholder Equity = 40.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -51.50% (Net Income -21.81b / Total Assets 42.35b)
RoE = -54.18% (Net Income TTM -21.81b / Total Stockholder Equity 40.26b)
RoCE = -48.33% (EBIT -22.04b / Capital Employed (Equity 40.26b + L.T.Debt 5.35b))
RoIC = -51.43% (negative operating profit) (NOPAT -21.68b / Invested Capital 42.15b)
WACC = 6.25% (E(10.73b)/V(18.35b) * Re(9.94%) + D(7.62b)/V(18.35b) * Rd(1.06%) * (1-Tc(0.02)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 64.52% ; FCFE base≈1.27b ; Y1≈906.0m ; Y5≈489.6m
Fair Price DCF = 45.79 (DCF Value 7.01b / Shares Outstanding 153.1m; 5y FCF grow -33.68% → 3.0% )
EPS Correlation: -54.89 | EPS CAGR: -2.45% | SUE: 0.00 | # QB: 0
Revenue Correlation: -50.07 | Revenue CAGR: 40.15% | SUE: 0.19 | # QB: 0